Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor

European Journal of Human Genetics

Volumn 17, Issue 10, 2009, Pages 1309-1313

  Ban, Maria ^a   Goris, An ^b   Lorentzen, Åslaug R ^c,d   Baker, Amie ^a   Mihalova, Tania ^e   Ingram, Gillian ^f   Booth, David R ^g   Heard, Robert N ^g   Stewart, Graeme J ^g   Bogaert, Elke ^b   Dubois, Bénédicte ^b   Harbo, Hanne F ^c   Celius, Elisabeth G ^c   Spurkland, Anne ^h   Strange, Richard ^e   Hawkins, Clive ^e   Robertson, Neil P ^f   Dudbridge, Frank ⁱ   Wason, James ⁱ   De Jager, Philip L ^j,k   Hafler, David ^k   Rioux, John D ^l   Ivinson, Adrian J ^m   McCauley, Jacob L ⁿ   Pericak Vance, Margaret ⁿ   Oksenberg, Jorge R ^o   Hauser, Stephen L ^o   Sexton, David ^p   Haines, Jonathan ^p   Sawcer, Stephen ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g UNIVERSITY OF SYDNEY   (Australia)

^h UNIVERSITY OF OSLO   (Norway)

ⁱ MRC BIOSTATISTICS UNIT   (United Kingdom)

^j HARVARD MEDICAL SCHOOL   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^m The Harvard Center for Neurodegeneration & Repair   (United States)

ⁿ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7 RECEPTOR; PROLINE; PROTEIN KINASE TYK2;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE FUNCTION; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70349629969     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.41     Document Type: Article

References (34)

1. Compston A, Coles A: Multiple sclerosis. Lancet 2008; 372: 1502-1517.
2. Hogancamp WE, Rodriguez M, Weinshenker BG: The epidemiology of multiple sclerosis. Mayo Clin Proc 1997; 72: 871-878.
3. Ebers GC, Sadovnick AD, Risch NJ: A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995; 377: 150-151.
4. Ebers GC, Yee IM, Sadovnick AD, Duquette P: Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Canadian Collaborative Study Group. Ann Neurol 2000; 48: 927-931.
5. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ: Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347: 1728-1730.
6. Jersild C, Svejgaard A, Fog T: HL-A antigens and multiple sclerosis. Lancet 1972; 1: 1240-1241.
7. Compston A, Confavreux C, Lassmann H et al: McAlpine's Multiple Sclerosis. Churchill Livingstone: Edinburgh, 2005.
8. Sawcer S, Ban M, Maranian M et al: A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005; 77: 454-467.
9. Yang Q, Khoury MJ, Friedman J, Little J, Flanders WD: How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 2005; 34: 1129-1137.
10. Lindsey JW: Familial recurrence rates and genetic models of multiple sclerosis. Am J Med Genet A 2005; 135: 53-58.
11. Gregory SG, Schmidt S, Seth P et al: Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39: 1083-1091.
12. Lundmark F, Duvefelt K, Iacobaeus E et al: Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007; 39: 1108-1113.
13. International Multiple Sclerosis Genetics Consortium T: Risk alleles for multiple sclerosis identified by a genome wide study. N Engl J Med 2007; 357: 851-862.
14. The International Multiple Sclerosis Genetics Consortium: Refining genetic associations in multiple sclerosis. Lancet Neurol 2008; 7: 567-569.
15. Hafler JP, Maier LM, Cooper JD et al: CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009; 10: 5-10.
16. Rubio JP, Stankovich J, Field J et al: Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun 2008; 9: 624-630.
17. The International Multiple Sclerosis Genetics Consortium: The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 2009; 10: 11-14.
18. Burton PR, Clayton DG, Cardon LR et al: Association scan of 14,500 non synonymous SNPs in four diseases identifies auto-immunity variants. Nat Genet 2007; 39: 1329-1337.
19. Poser CM, Paty DW, Scheinberg L et al: New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
20. McDonald WI, Compston A, Edan G et al: Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
21. Purcell S, Cherny SSD Sham PC: Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
22. WiggDnton JE, Abecasis GR: PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005; 21: 3445-3447.
23. O'CoAnell JR, Weeks DE: PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
24. Dudbridge F: Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.
25. Minegishi Y, Saito M, Morio T et al: Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006; 25: 745-755.
26. Tokumasa N, Suto A, Kagami S et al: Expression of Tyk2 in dendritic cells is required for IL-12, IL-23, and IFN-gamma production and the induction of Th1 cell differentiation. Blood 2007; 110 553-560.
27. Watford WT, O'Shea JJ: HAman tyk2 kinase deficiency: another primary immunodeficiency syndrome. Immunity 2006; 25: 695-697.
28. Graham DS, Akil M, Vyse TJ: Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families. Rheumatology (Oxford) 2007; 46: 927-930.
29. Sigurdsson S, Nordmark G, Goring HH et al: Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005; 76: 528-537.
30. Shaw MH, Boyartchuk V, Wong S et al: A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci USA 2003; 100: 11594-11599.
31. Satoh JI, Obayashi S, Misawa T et al: Neuromyelitis optica/Devic's disease: Gene expression profiling of brain lesions. Neuropathology 2008; 28: 561-576.
32. Phan UT, Arunachalam B, Cresswell P: Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J Biol Chem 2000; 275: 25907-25914.
33. Barjaktarevic I, Rahman A, Radoja S et al: Inhibitory role of IFN-gamma-inducible lysosomal thiol reductase in T cell activation. J Immunol 2006; 177: 4369-4375.
34. Hohol MJ, Orav EJ, Weiner HL: DAsease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999; 5: 349-354.